Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease
Recruiting
N/A
Interventional Study
Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigator aim to identify the role of inorganic pyrophosphate and other anti-calcifying molecules in vascular disease in children with chronic kidney disease, with a view to developing therapeutic approaches aimed at limiting the onset of vasculopathy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
All groups :
* Minor patients (\<18 years)
* Patients of both sexes
* Informed patients and parents who have signed the informed consent form
* Patients affiliated to social security
Control group :
\- Patients with no particular pathology undergoing surgery and receiving a p…
Contacts